H.R. 1 — the One Big Beautiful Bill Act signed by President Trump in 2025 — is not directly hostile to the idea of enrolling incarcerated people in Medicaid before their release. The law never mentions it. But by imposing work requirements, tighter eligibility checks, and budget cuts on state Medicaid agencies, it has effectively disabled a bipartisan effort that was gaining momentum. The mechanism is administrative resource displacement: the new mandates consume the finite staff time, funding, and institutional capacity that agencies need to build and maintain pre-release enrollment programs. The work isn’t prohibited; it’s made unaffordable in time and resources.

At least three states have paused their pre-release programs because of the law. Oregon, whose Medicaid director Emma Sandoe said bringing Medicaid behind bars aligned with the state’s long-standing push to expand coverage, was forced to focus on other priorities. “What physically can be done with the amount of time, with the amount of resources available, is limited,” Sandoe said. Rhode Island cited insufficient funding. Michigan formally archived its application in December 2025, writing, “This initiative will be archived and considered for future efforts to support reentry populations.” The language signals intent, not abandonment — though state-level political alignment with the federal direction may also have played a role; the archival language is consistent with both readings.

Louisiana became the first state to receive approval under the Trump administration in April 2026, but the approval went through what deputy Medicaid director Pete Croughan called an “intensive delete process.” Benefits were limited to mental health care, medications for addiction treatment, infectious disease screening, and medical equipment such as wheelchairs. Primary care inside jails and prisons was excluded. Croughan’s triage justification captured the tension: “There’s definitely evidence that folks with untreated mental health and addiction issues are more likely to die. So we have to solve for that. I don’t know that there’s evidence for that for someone with untreated knee pain.”

This narrowing creates a chronic illness coverage gap. Lauren Brinkley-Rubinstein, a Duke University professor who studies the health impacts of incarceration, noted that many people leaving incarceration carry multiple chronic illnesses that have often been inadequately treated inside. Under Louisiana’s plan, newly released individuals will need to find care for those conditions on their own, on top of finding housing, food, and employment. “Going to the doctor and refilling that prescription is just never going to rank higher than those other things,” she said. “It makes it more likely that they are going to come back through the [jail or prison] door.”

Two converging forces are at work. H.R. 1 squeezes state capacity through resource displacement. Trump-era CMS squeezes program content through the “intensive delete process.” Different mechanisms, same direction.

The contrast with Washington state’s program is sharp. Under a Biden-era approval, four states — California, Washington, Montana, and New Hampshire — began providing Medicaid coverage to people inside, screening tens of thousands for substance use disorder and connecting them to care before release. Washington officials reported that individuals who received Medicaid before release were less likely to return to jail or prison. The individual testimony of Cody Coughenour, a 47-year-old who had been jailed at least half a dozen times, illustrates the difference. After earlier releases, jailers gave him a phone number to call to enroll in Medicaid; the call would go to voicemail or he would be placed on a long hold, a delay that sent him to his dealer and eventually back to jail. December 2025 was different: he left with medications for his anxiety, his Medicaid card in hand, and appointments already scheduled. “We went straight to the treatment facilities,” he said. “What people are running away from, that’s what they’re going to run into.”

The Washington vs. Louisiana design contrast is a central analytical crossroads. Washington’s pre-loading access model — appointments scheduled, card in hand, immediate treatment entry — is an alternative to Louisiana’s minimalist approach. Washington’s data suggests that broader coverage reduces recidivism, though the claim is correlational rather than controlled. Louisiana’s retained services — especially medications for opioid use disorder — are likely the most impactful for keeping people alive, as Brinkley-Rubinstein acknowledged, but the exclusion of primary care leaves a gap that may drive individuals back through the door.

The structural vulnerabilities that H.R. 1 has exposed were present even before the law. Dr. Marc Stern, a Washington doctor who has spent 25 years working inside prisons and jails, described the core deficit: “What we really needed was a translator between the Medicaid agency and the jails. Because Medicaid doesn’t speak jail, and jail doesn’t speak Medicaid.” The translation gap — different data formats, time horizons, and institutional logics — was a structural weakness that informal coordination could paper over but not solve. H.R. 1 exposed it by stripping away the bandwidth needed to maintain that coordination. Stern is named for Washington, where a program exists; no equivalent figure is surfaced in Oregon, Rhode Island, or Michigan. Whether any of the four implementing states has institutionalized joint Medicaid-corrections training as a standalone program, or relies on informal coordination that collapses when key staff depart, remains unanswered.

The work requirement itself is structurally misaligned with the target population. H.R. 1’s work requirements and tighter eligibility checks were designed for a non-incarcerated population with employment capacity; applying them to people who are, by definition, not in the workforce creates a mismatch at the eligibility-design level, mirroring the operational mismatch Stern identified. (Whether H.R. 1 includes explicit exemptions for incarcerated individuals is not confirmed in available material.)

Louisiana’s alternative funding choice introduces its own fragility. The state substituted the Rural Health Transformation Fund (RHTP) for full federal startup dollars. The RHTP was created by H.R. 1 itself — the same statute that imposed the budget and workload pressures narrowing Louisiana’s program. The state’s autonomy from direct CMS grant constraints is tethered to the political durability of the very law that caused the disruption. If appropriations under H.R. 1’s framework shift, or if political conditions sustaining the fund change, Louisiana loses its alternative funding source.

The role architecture of this conflict reveals critical gaps. CMS is acting as both referee (enforcing the rules) and arbiter (deciding waivers); no independent body watches whether the process is fair to the most affected parties. The program’s animating purpose — reducing the asymmetry between incarcerated people and the healthcare system — is contracting without compensating expansion. The equalizer role is being withdrawn. The bridge-builder role — cultivating relationships between Medicaid bureaucracies and correctional systems — has not been killed but starved of bandwidth; as Sandoe’s quote makes clear, the bridge is still drawn on the map, but the builders have been reassigned. The teacher role — the translator function Stern identified — is unfilled in the paused states. The witness role is active: Brinkley-Rubinstein’s research, Washington’s recidivism data, and NPR reporting make the disruption visible. But there is no recipient institution in Congress or at CMS that converts that visibility into policy change. A CMS spokesperson said the agency “understands that states may face varying challenges during implementation” and “remains committed to supporting all states throughout this process,” but the statement carries no specific resource commitment or programmatic change.

A fiscal-conservative case for pre-release coverage — reduced recidivism means reduced incarceration costs and reduced uncompensated emergency care — exists in the data but has not been organized into a coherent campaign. The 19 states that held Biden-era waivers could present system-level cost-effectiveness data to CMS and Congress. That coalition has not materialized. The argument is available; the organizing force is not.

The hypothesized feedback loop that the causal analysis cannot fully close remains a central uncertainty: reduced pre-release coverage may produce worse reentry outcomes, which increase recidivism, which strains state resources further, which reduces capacity for pre-release programs. Brinkley-Rubinstein frames the recidivism connection as inference; no incarceration-cost or Medicaid-agency-capacity metrics are provided to test whether the cycle is empirically real. The policy is designed to disrupt the cycle; the current trajectory weakens the disruption mechanism.

Several open questions will determine whether the bifurcation between paused and active states represents a stable equilibrium or the leading edge of a larger contraction: Does Louisiana’s narrower scope produce measurably worse health or recidivism outcomes than Washington’s broader coverage, and what is the essential coverage threshold for effective pre-release enrollment? Will CMS funding for existing pre-release programs continue under H.R. 1’s budget constraints, or will additional states follow Michigan’s archival? Can community health centers and federally qualified health centers absorb some of the equalizing function in states where pre-release Medicaid has been paused? And has the translation gap been closed through institutionalized programs in the four implementing states, or does it remain structurally vulnerable?

What emerges from the evidence is a story about indirect disruption — not a partisan assault on a specific program, but a resource displacement that, combined with an administrative “delete process,” is quietly dismantling a bipartisan initiative that had shown measurable results. The program’s bipartisan character is preserved in intention but hollowed out in operation. The same agencies that sought approval are pausing because the resource environment changed. The individuals who need the coverage — like Cody Coughenour — are left with the same fragmented system the program was designed to replace.

Analytical techniques used in this piece

This analysis applies the methods below. Each links to a short, plain-English explainer you can read and reuse.

Relationship Mapping
Extracts the network of ties among people, institutions, and entities.
Stakeholder Mapping
Charts the parties to a situation — their interests, power, and alignments.
The Third Side
Takes the vantage of the surrounding community that has a stake in resolving a conflict (Ury).